Important safety information Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic, Rybelsus, and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including MTC, a type of thyroid cancer
AOD 9604 Side Effects: What Six Clinical Trials Found The safety data on AOD 9604 is stronger than for most investigational peptides, precisely because six formal clinical trials were conducted before development halted
Retatrutide is an investigational research compound, not an approved medicine
Refrigeration at 28C and use within 14 days is non-negotiable for maintaining compound stability
Skin Repair & Anti-Aging Benefits
As a 16-amino-acid peptide, it would likely be degraded by digestive enzymes if swallowed